- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01051973
Cognitive Behavior Therapy (CBT) Compared to Stress Management for Irritable Bowel Syndrome
Internet-delivered Cognitive Behavior Therapy Compared to Stress Management in the Treatment of Irritable Bowel Syndrome - A Randomized Controlled Study.
The study aims to compare two manualized treatments. They are based on cognitive behavior therapy or stress management. Both treatments are delivered via an internet application and the patients' work with the treatments is supported through online contact with a therapist. The treatments last for 10 weeks.
Approximately 200 patients will be included in the study and randomized to either condition.
The study hypothesis is that CBT will be superior to stress management on the main outcome measure, which is IBS symptom severity measured over 4 weeks.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 181 86
- Internetpsykatrienheten, M57, Psykiatri sydväst
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnosis of IBS given by physician
- At screening fulfilling Rome III-criteria for IBS
Exclusion Criteria:
- Severe depression
- Suicidal ideation
- Presence of unexplained IBS alarm symptoms
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive behavior therapy
|
A 10-week treatment based on exposure to symptoms and related feelings.
|
|
Active Comparator: Stress management
|
A 10-week stress management treatment including applied relaxation and dietary advice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of IBS symptoms
Time Frame: During 4 consecutive weeks before randomization
|
The Gastrointestinal symptom rating scale - IBS version.
Mean of four weeks of assessment.
|
During 4 consecutive weeks before randomization
|
|
Level of IBS symptoms
Time Frame: During 4 consecutive weeks after treatment completion (10 weeks after randomization)
|
The Gastrointestinal symptom rating scale - IBS version.
Mean of four weeks of assessment.
|
During 4 consecutive weeks after treatment completion (10 weeks after randomization)
|
|
Level of IBS symptoms
Time Frame: During 4 consecutive weeks 6 months after treatment completion
|
The Gastrointestinal symptom rating scale - IBS version.
Mean of four weeks of assessment.
|
During 4 consecutive weeks 6 months after treatment completion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life
Time Frame: Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
The Irritable Bowel Syndrome Quality of Life Instrument
|
Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
|
Use of health care resources and societal production loss because of illness
Time Frame: Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry
|
Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
|
Level of IBS-symptoms
Time Frame: Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
IBS-Severity Scoring System
|
Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
|
Anxiety related to gastrointestinal symptoms
Time Frame: Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
Visceral Sensitivity Index
|
Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
|
Level of daily stress
Time Frame: Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
Perceived stress scale
|
Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
|
Subjective relief of IBS-symptoms
Time Frame: Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
One question: "In the past week, have you had adequate relief from IBS pain or discomfort?"
|
Before randomization, after treatment (10 weeks after randomization) and 6 months after treatment completion
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IBS-X
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.